Back

All-cause mortality in cardiac resynchronization therapy is predicted by the degree of LV reverse remodeling at mid-term follow-up

18 June 2017 (15:30 - 16:30)
Organised by:
Congress Presentation Part of: Moderated Poster session 2 - CRT, indications and outcome Results (Resynchronization therapy) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Doctor Giampiero Maglia

Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro (Italy)

9 More presentations in this session

Presentation thumbnail
Left ventricular pacing polarity and survival following cardiac resynchronization therapy
Doctor S. Mittal (Ridgewood, US)
Abstract Slides
Presentation thumbnail
Comprehensive economic analysis of automatic optimization algorithms in cardiac resynchronization defibrillators (CRT-Ds): Markov modelling under the Italian, Spanish and UK healthcare settings
Doctor A. Maan (Cranston, US)
Abstract Slides
Presentation thumbnail
Relationship between indication for cardiac resynchronization therapy implantation and long-term survival
Doctor S. Mittal (Ridgewood, US)
Abstract Slides
Presentation thumbnail
Adherence to ESC guidelines class I was associated to better prognosis, clinical response and LV reverse remodeling in a large real-world CRT population.
Doctor A. Ferraro (Rivoli, IT)
Abstract
Presentation thumbnail
Effect of gender on patient selection for cardiac resynchronisation therapy
Professor A. Quesada Dorador (Valencia, ES)
Abstract Slides

Access the full session

Session thumbnail
Moderated Poster session 2 - CRT, indications and outcome

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June 2017 15:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources